4 Firms Steer Cancer-Focused Biotech's $125M IPO Launch
Swiss oncology firm ADC Therapeutics SA on Monday set a price range for an estimated $125 million initial public offering steered by four law firms, adding to a recent wave of...To view the full article, register now.
Already a subscriber? Click here to view full article